NCT01980875 2018-11-19Efficacy and Safety of Idelalisib in Combination With Obinutuzumab Compared to Chlorambucil in Combination With Obinutuzumab for Previously Untreated Chronic Lymphocytic LeukemiaGilead SciencesPhase 3 Terminated57 enrolled 12 charts